Patents by Inventor Jeffrey L. Lillard

Jeffrey L. Lillard has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20210015855
    Abstract: The present disclosure generally relates to the medical use of compositions comprising a mineral salt and a sulfonic acid for prevention and/or treatment of one or more mucosal diseases, disorders, or conditions or one or more dermal diseases, disorders, or conditions.
    Type: Application
    Filed: August 25, 2020
    Publication date: January 21, 2021
    Applicant: BMG PHARMA S.P.A.
    Inventors: William A. Goolsbee, Jeffrey L. Lillard
  • Patent number: 10786531
    Abstract: The present disclosure generally relates to the medical use of compositions comprising a mineral salt and a sulfonic acid for prevention and/or treatment of one or more mucosal diseases, disorders, or conditions or one or more dermal diseases, disorders, or conditions.
    Type: Grant
    Filed: June 24, 2019
    Date of Patent: September 29, 2020
    Assignee: BMG PHARMA SPA
    Inventors: William A. Goolsbee, Jeffrey L. Lillard
  • Publication number: 20190307792
    Abstract: The present disclosure generally relates to the medical use of compositions comprising a mineral salt and a sulfonic acid for prevention and/or treatment of one or more mucosal diseases, disorders, or conditions or one or more dermal diseases, disorders, or conditions.
    Type: Application
    Filed: June 24, 2019
    Publication date: October 10, 2019
    Applicant: BMG PHARMA SPA
    Inventors: William A. Goolsbee, Jeffrey L. Lillard
  • Publication number: 20150190425
    Abstract: The present disclosure generally relates to the medical use of compositions comprising a mineral salt and a sulfonic acid for prevention and/or treatment of one or more mucosal diseases, disorders, or conditions or one or more dermal diseases, disorders, or conditions.
    Type: Application
    Filed: December 24, 2014
    Publication date: July 9, 2015
    Inventors: William A. Goolsbee, Jeffrey L. Lillard
  • Publication number: 20120245080
    Abstract: The present disclosure generally relates to the medical use of compositions comprising a mineral salt and a sulfonic acid for prevention and/or treatment of one or more mucosal diseases, disorders, or conditions or one or more dermal diseases, disorders, or conditions.
    Type: Application
    Filed: April 15, 2010
    Publication date: September 27, 2012
    Applicant: BMG PHARMA LLC
    Inventors: William A. Goolsbee, Jeffrey L. Lillard
  • Patent number: 5405001
    Abstract: A closure structure or cap for a two compartment vial includes a resilient stopper having a cylindrical body with a lower shoulder portion adapted for sealing fit in the mouth of the vial and a second circumferential shoulder at is upper end. A substantially rigid hollow cylindrical sleeve is configured to surround the mouth of the vial, and has, at its upper end, integrally constructed downwardly projecting longitudinally split fingers dimensioned to embrace the stopper, with the bottoms of the split fingers engaging and resting upon the lower shoulder portion of the rubber stopper. An internal groove in the split fingers engages the lower edge of a second shoulder of the stopper thereby gripping the stopper. A locking member is disposed between the longitudinally split fingers and the inside walls of the hollow cylindrical sleeve or cap, forming means to prevent spreading of the fingers and thereby preventing the loosening of the grip of the fingers on the stopper.
    Type: Grant
    Filed: April 29, 1994
    Date of Patent: April 11, 1995
    Assignee: Clinetics Corporation
    Inventor: Jeffrey L. Lillard